Lamotrigine
Product Images NDC 68071-2960

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 68071-2960). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2960 6)

Label for Lamotrigine 150 mg tablets by NuCare Pharmaceuticals, Inc. The label indicates a package count of 60 tablets, with each tablet containing 150 mg of Lamotrigine. The tablets are described as round, flat, beveled-edged, white to off-white with a bisect; one side of the bisect is debossed with the logo 'ZC' and '81', the other side is plain. Packaging and manufacturer details are included along with storage temperature instructions and prescription-only status.*

FDA Label Image

Image (A8e89916 Ae5a 48af 9da1 8b9288d977fd 388 2)

The image shows the face of a white round tablet imprinted with 'ZC 79'. This is a tablet form pharmaceutical product identified as Lamotrigine, labeled by NuCare Pharmaceuticals, Inc. No further strength or dosage information is visible on the tablet face.*

FDA Label Image

Structured Formula For Lamotrigine (Fd77496d 56c7 476b 9231 0298034b1a17 01)

Chemical structure of Lamotrigine. The diagram shows the molecular composition and arrangement of atoms, including chlorine atoms attached to a benzene ring and a triazine ring with amino groups.*

FDA Label Image

Lamotrigine Tablet (Fd77496d 56c7 476b 9231 0298034b1a17 02)

A line graph depicting failure probability (%) versus time in weeks, comparing Lamotrigine and placebo. Both lines feature markers indicating censored data points. The graph illustrates changes in failure probability over approximately 90 weeks for Lamotrigine and placebo groups.*

FDA Label Image

Lamotrigine Tablets (Fd77496d 56c7 476b 9231 0298034b1a17 03)

A Kaplan-Meier failure probability curve comparing Lamotrigine and placebo over a period of up to 80 weeks. The y-axis represents failure probability in percentage, while the x-axis shows weeks. The graph includes censoring marks and illustrates differences in failure rates between Lamotrigine and placebo groups across time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.